Navigation Links
SS-B (La) Anti-Extractable Nuclear Antigen (ENA) Antibodies Kit

ProductsSS-B (La) Anti-Extractable Nuclear Antigen (ENA) Antibodies Kit
Company IMMCO Diagnostics
Item SS-B (La) Anti-Extractable Nuclear Antigen (ENA) Antibodies Kit
Features 
Description Enzyme-linked immunosorbent assays for the detection and quantitation of IgG antibodies to extractable nuclear antigens (ENA) SS-B (La) in human serum. SS-A (Ro) and SS-B (La) antibodies aid in the diagnosis of SLE, subacute cutaneous lupus erythematosus (SCLE) and Sjgrens syndrome.
Info IMMCO Diagnostics
Customer Service: (800) 537-8378
Web site: http://www.immcodiagnostics.com

Related medicine products :

1. Sm/RNP Anti-Extractable Nuclear Antigen (ENA) Antibodies Kit
2. Sm Anti-Extractable Nuclear Antigen (ENA) Antibodies Kit
3. SS-A (Ro)Anti-Extractable Nuclear Antigen (ENA) Antibodies Kit
4. Kansas Nuclear Fragment Forceps
5. ENA Screen EIA Auto-Immune Markers 012-MDKES1 Extractable Nuclear Antigens
6. Nuclear Cardiology Facility Planning Services
7. ImmuLisa Anti-Nuclear Antibody (ANA) Screen ELISA
8. Epstein-Barr Nuclear Antigen (EBNA) ACIF (Anti-Complement Immunofluorescence)
9. Anti-Neuronal Nuclear Antibody (ANNA), CSF
10. Anti-Nuclear Antibody (ANA) with Reflex to dsDNA, RNP, Smith, SSA, & SSB Antibodies
11. Anti-Nuclear Antibodies (ANA), IgG Screen with Reflex to IFA Titer
The Coreograft PLIF Allograft System is a wedge shaped, cortical strut designed to provide anterior column support and facilitate interbody fusion. This system includes a specially designed instrumen
Duet Lumbar Allografts are comprised of a raised cancellous inner core providing biomechanical properties for rapid healing. Specially designed instruments facilitate the insertion of Duet Allografts
VG2 PLIF Allograft is comprised of two cortical planks of bone surrounding a cancellous center. The cortical planks provide strength for anterior column support. The cancellous bone provides a lattic
Ramp allograft is machined from cortical bone to combine column support. The graft is machined with a textured surface for increased stability and resistance to graft migration. This allograft can be
Medicine Products:
(Date:7/25/2008)...ients consumers tips and encourages them to, ,Spe...G, Pa., July 25 /PRNewswire-USNewswire/ -- The Pen..."National Patient Safety Day" which,is a national ...,participate fully in their healthcare by asking q...eir surgery or illness., "We understand the impor...
(Date:7/25/2008)...f Marketing Exclusivity Begins -, CORONA, Calif.,...uticals, Inc. (NYSE: WPI ), a leading specialty p...bsidiary has commenced commercial,shipment of its ... the 40mg,strength from its Davie, Florida manufac...atson has 180 days of marketing exclusivity for be...
(Date:7/25/2008)...rapy Alliance to be presented at Fenway Park ...I., July 25 /PRNewswire/ -- CVS/pharmacy announced...ing $4.4 million in just 21 days,through its annua...This is,the seventh year of the annual fundraising...illion for ALS research. This year,s fundraiser to...
(Date:7/25/2008)...e Retina Group of New York will present an educati...ation especially designed for seniors. The lecture... 116 Merritts Road, Farmingdale, NY 11735, 1:00 to...e and refreshments will be provided. The phone num... Hicksville and Hauppauge, NY ...
Breaking Medicine News(10 mins):Health News:Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3
...thod of treating childhood brain tumours, aimed at...to be trialled at hospitals around the US. Researc...blastoma – the most common malignant childhood bra...ower radiation and increased chemotherapy doses th...
...only used in vitro fertilisation (IVF) technique i...e the risk of babies being born with abnormalities... Pasteur Institute in Paris, France, say that men ...ther, more serious genetic faults that can be pass...
...g to a new study infants born during the night hav...h than those born during the day. There is also a ... which may be partly explained by hospital staff s...ours between 5pm and 1am are high risk periods for...
...ng drugs via nasal spray might overcome a major ob...according to researchers.Based on early studies in...er's Research Center in St. Paul, Minnesota, repor...nā€ could breach the blood-brain barrier, which pro...
Other Medicine News:Health News:Nasal Spray Could Take Drugs Directly to Brain 2
(Date:7/24/2008)...IEW, Calif., July 24 /- Ale...ed today that it has initiated,its second Phase 3 ...,AZ-004 is an inhalation product candidate being d...atients with schizophrenia or bipolar disorder.,Al...apid pharmacokinetic,(PK) properties resulting fro...
(Date:7/24/2008)...July 24 /- MacroChem Corpor...esults of a Phase 2 clinical trial,involving 37 pa...,open-label efficacy and safety study of EcoNail, ...onychomycosis (nail fungus). The composite,primary..." defined as,negative mycology (negative fungal cu...
(Date:7/23/2008)..., July 23 /PRNewswire-USNewswire/ -- The following... Chairman Conyers, Ranking Member Smith, and Membe... to testify today., Since I appeared before this ...n better acquainted with the talented and dedicate... the work they do, and I have come to,appreciate t...
(Date:7/23/2008)...cused on IND-Enabling Work with Protein Therapeuti...Complement System, CAMBRIDGE, Mass., July 23 /PRN...ced it has initiated a corporate growth plan with ... executive officer and the,establishment of its he...ds,Woodruff Emlen, M.D., a co-founder of the compa...
Breaking Medicine Technology:Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Early Weight Gain Can Mean Heart Trouble Later in Life 5558 1Early Weight Gain Can Mean Heart Trouble Later in Life 5558 2Early Weight Gain Can Mean Heart Trouble Later in Life 5558 3Breast cancer research and inkjet tissue printing get NSF boost 1106 1Breast cancer research and inkjet tissue printing get NSF boost 1106 2Fourteen Global Experts Comment on the Safety and Use of Genetically Modified Food Crops 5553 1Fourteen Global Experts Comment on the Safety and Use of Genetically Modified Food Crops 5553 2Fourteen Global Experts Comment on the Safety and Use of Genetically Modified Food Crops 5553 3Fourteen Global Experts Comment on the Safety and Use of Genetically Modified Food Crops 5553 4Packard Childrens Hospital Foundation Provide Financial Support for School Nurses in San Jose 5549 1Packard Childrens Hospital Foundation Provide Financial Support for School Nurses in San Jose 5549 2Packard Childrens Hospital Foundation Provide Financial Support for School Nurses in San Jose 5549 3Packard Childrens Hospital Foundation Provide Financial Support for School Nurses in San Jose 5549 4
...alif., July 5 /PRNewswire-FirstCall/ -- Nuvelo,In...he ANTHEM,(Anticoagulation with rNAPc2 To Help Eli...mbinant nematode anticoagulant protein c2,(rNAPc2)...preclinical data evaluating rNAPc2 in mouse models...ting the mechanism of NU172, a,short-acting, direc...
... Texas--(BUSINESS WIRE)--Jul 5, 2007 - Repros,Ther... an article,has been published in the July 1, 2007...for a new approach to the treatment of,breast canc...s from,a study conducted in an accepted in vivo ra...in collaboration with scientists,from the Universi...
Other Medicine Technology:Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst,Congress of the International Society on Thrombosis and Haemostasis 2Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst,Congress of the International Society on Thrombosis and Haemostasis 3Peer Reviewed Journal Article Indicates Repros' Proellex Exhibits,Potential for New Approach to the Treatment and Prevention of,Breast Cancer 2Peer Reviewed Journal Article Indicates Repros' Proellex Exhibits,Potential for New Approach to the Treatment and Prevention of,Breast Cancer 3Peer Reviewed Journal Article Indicates Repros' Proellex Exhibits,Potential for New Approach to the Treatment and Prevention of,Breast Cancer 4